Healthcare

Key data points: The growth forecast = 5.4% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global carbapenem-based antibiotic market to 2030 by type (meropenem, imipenem, doripenem, tebipenem, and others), indication (intra-abdominal infections, urinary tract infections, pneumonia, bacterial meningitis, skin & skin structure infections, acute pelvic infections, and others), distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 6.2% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global pharmaceutical & biotechnology environmental monitoring market to 2030 by type (monitoring equipment, media, software, and microbiology service), application (pharmaceutical industrial, biotechnology industrial, and academic & research institutions), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $2.1 billion, growth forecast = 10.8% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global naloxone market to 2030 by strength (2.0 mg/0.1 ml, 4.0 mg/ml, 1 mg/ml, 0.4 mg/ml, and others), route of administration (intranasal, intramuscular/subcutaneous, and intravenous), distribution channel (hospitals, clinics, retail pharmacies, emergency medical, services, military facilities, miscellaneous facilities, online pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $2.5 billion, growth forecast = 6.3% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global myasthenia gravis treatment market to 2030 by treatment type (cholinesterase inhibitors, chronic immunomodulators, monoclonal antibodies, rapid immunotherapies, thymectomy, and others), end use (hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $13.8 billion, growth forecast = 5.0% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global radioligand therapy market to 2030 by isotope (fluorine – 18, gallium - 68, lutetium - 177, and others), targeted receptor (prostate-specific membrane antigen, somatostatin receptor, epidermal growth factor receptor, and others), indication (prostate cancer, neuroendocrine tumors, breast cancer, and others), end use (hospitals & clinics, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $44.0 billion, growth forecast = 9.4% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global dyslipidaemia drug market to 2030 by drug type (non-statins drugs and statins drugs), application (hospital pharmacy, retail pharmacy, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 5.3% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global grass-fed beef liver capsule market to 2030 by type (degrease and non-degreasing), application (online sale, offline sale, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 6.1% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global diuretic agent market to 2030 by type (thiazide diuretics, loop diuretics, potassium-sparing diuretics, and others), application (hospital, clinic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 5.2% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global ezetimibe tablet market to 2030 by type (10 tablets per box, 30 tablets per box, and others), application (hospital, clinic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 10.2% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global ceftizole sodium for injection market to 2030 by type (0.5g, 1.0g, 1.5g, and 2.0g), application (hospital, clinic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 2.4% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global ciprofloxacin hydrochloride tablet market to 2030 by type (0.25g and 0.5g), application (hospital, clinic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 5.4% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global poloxamer 188 excipient market to 2030 by type (micronized poloxamer 188 and ordinary poloxamer 188), application (injectable formulation, oral formulation, and topical formulation), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 5.2% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global pharmaceutical grade peg-40 stearate market to 2030 by type (powered and flaky), application (oral formulation, topical formulation, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 10.3% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global fucoidan powder market to 2030 by type (purity: 80%, purity: 85%, and others), application (pharmaceutical, health care product, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 4.8% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global brucea javanica oil emulsion injection market to 2030 by type (10ml and 20ml), application (lung cancer, gastrointestinal cancer, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 6.3% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global tramadol hydrochloride tablet market to 2030 by type (50mg, 100mg, and others), application (hospital, clinic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 6.1% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global meloxicam tablet market to 2030 by type (original drug and generic drug), application (rheumatoid arthritis, osteoarthritis, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 17.2% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global alpha mannosidosis market to 2030 by type (bone marrow transplant and enzyme replacement therapy), indication (type I, type II, and type III), end use (hospitals and specialty clinics), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 28.5% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global trastuzumab biosimilar market to 2030 by product (ogivri, herzuma, ontruzant, trazimera, and others), indication (adjuvant breast cancer, metastatic breast cancer, metastatic gastric cancer, and others), distribution channel (hospital pharmacy and online pharmacy), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 2.4% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global TNF alpha inhibitor market to 2030 by drug (remicade (infliximab), enbrel (etanercept), humira (adalimumab), cimzia (certolizumab pegol), and simponi (golimumab)), route of administration (oral, subcutaneous, intravenous, and others), disease type (inflammatory bowel disease, psoriatic arthritis, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $5.5 billion, growth forecast = 17.3% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global radiotheranostic market to 2030 by radioisotope (iodine-131, iodine-123, gallium-68, lutetium-177, 18F with Y-90, and others), approach (targeted therapeutic and targeted diagnostic), application (oncology and non-oncology), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $7.2 billion, growth forecast = 10.3% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global opioid use disorder (oud) market to 2030 by drug type (agonist and antagonist), age group (19 to 39, 40 to 59, and age 60 and over), route of administration (oral, intravenous, and sublingual), distribution channel (hospital pharmacy and retail pharmacy), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 4.2% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global acne drug market to 2030 by type (comedonal, inflammatory, cystic, and postsurgical/wound), therapeutic class (retinoid, antibiotic, hormonal agent, combination, and others), mode of administration (topical, oral, and injectable), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $15.77 billion, growth forecast = 9.6% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global psoriatic arthritis treatment market to 2030 by drugs class (non-steroidal anti-inflammatory drugs, non-biologic disease modifying anti-rheumatic drugs, biologic disease modifying anti-rheumatic drugs, and others), route of administration (oral, parenteral, and topical), distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $19.47 billion, growth forecast = 8.7% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global prostate cancer market to 2030 by drug class (hormonal ADT, AR-directed therapies, cytotoxic agents,bone metastases, therapeutic vaccines, PARP inhibitors, kinase inhibitors, and PSMA-targeted radioligands), distribution channel (hospital pharmacies, drug store & retail pharmacies, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $20.30 billion, growth forecast = 6.0% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global neutropenia treatment market to 2030 by treatment (colony-stimulating factor, antibiotics, antifungals, and antivirals), distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $7.4 billion, growth forecast = 5.8% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global decubitus ulcer treatment product market to 2030 by type (air fluidized beds, foam mattresses, alternative air pressure mattresses, low air loss beds, and local area support products), application (online and offline), distribution channel (hospitals clinics, public hospitals, private clinics, retail pharmacies & drug stores, e-commerce, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $13.7 billion, growth forecast = 10.4% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global colony stimulating factor market to 2030 by type (macrophage–colony-stimulating factor, multiple-colony-stimulating factor or interleukin 3, granulocyte-macrophage–colony-stimulating factor, and granulocyte–colony-stimulating factor), dosage (injection, tablets, capsule, and others), application (aplastic anemia, bone marrow transplantation, neutropenia, neutropenia associated with chemotherapy, neutropenia associated with radiation, and peripheral progenitor cell transplantation), end use (hospitals, specialty clinics, homecare, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 11.2% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global nano magnetic bead market to 2030 by type (silica nano magnetic beads, polymer nano magnetic beads, and others), application (protein & antibody purification, immunoprecipitation, sample preparation, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecasts = 6.1% annually for the for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecastss in the global darifenacin hydrobromide market to 2030 by type (7.5mg and 15mg), application (hospital, clinic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 6.2% annually next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global fentanyl market to 2030 by route of administration (sublingual tablet, buccal tablet, oral film, and others ), end use (hospital, oncology centers, surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 7.9% annually next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global cinepazide maleate api market to 2030 by type (purity≤98% and purity > 98%), application (tablet and injection), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 2.9% annually next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global cefteram pivoxil tablet market to 2030 by type (50mg and 100mg), application (hospital, clinic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 5.5% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global pharmaceutical glass packaging market to 2030 by product (bottles, vials, ampoules, cartridges & syringes, and others), drug type (generic, branded, and biologic), application (oral, injectable, nasal, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $19.9 billion, growth forecast = 13.5% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global advanced therapy medicinal products market to 2030 by product (cell therapy, CAR-T therapy, gene therapy, and tissue engineered product), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $83.6 billion, growth forecast = 6.5% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global chronic kidney disease market to 2030 by treatment (drugs and dialysis), end use (hospital, dialysis center, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 10.2% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global neuroendocrine tumor treatment market to 2030 by product (somatostatin analogs (SSAs), targeted therapy, and chemotherapy), indication (lung, pancreas, gastrointestinal, and others), end use (hospital, clinic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $0.6 billion, growth forecast = 5.1% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global pupillometer market to 2030 by product (table-top and hand-held), type (video and digital), application (ophthalmology, oncology, neurology, and others), end use (hospitals, eye clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $3.5 billion, growth forecast = 6.6% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global myocardial infarction market to 2030 by route of administration (oral and injectable), drug class (antiplatelet agents, glycoprotein IIb/IIIa inhibitors, antithrombotic agents, beta-adrenergic blockers, vasodilators, angiotensin-converting enzyme (ACE) inhibitors, angiotensin-receptor blockers, and analgesics), distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 4.3% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global heparin-induced thrombocytopenia market to 2030 by treatment drug (argatroban, lepirudin, danaparoid, and others), end use (hospital, specialty clinic, academic & research organization, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 2.2% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global golimumab (simponi) market to 2030 by type (100Mg/Ml, 50Mg/Ml, and 10Mg/Ml), application (hospital, clinic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 6.7% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global doxorubicin market to 2030 by drug formulation (lyophilized powder and doxorubicin), distribution channel (hospital pharmacy, retail pharmacy, and online pharmacy), application (bladder cancer, kaposi sarcoma, leukemia, lymphoma, breast cancer, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $5.7 billion, growth forecast = 2.4% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global glycoprotein market to 2030 by type (n-linkage, o-linkage, and others), techniques (molecular reagent and mass spectrometry), application (hospital, research institute, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 5.6% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global pivka ii antigen market to 2030 by type (serum, plasma, and others), application (hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 3.2% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global injectable benzodiazepine market to 2030 by type (long-acting drugs and short-acting drugs), application (surgical anesthesia, sedation, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 8.3% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global esophageal cancer market to 2030 by type (esophageal squamous-cell carcinoma, esophageal adenocarcinoma, and others), treatment type (chemotherapy, targeted therapy, and others), route of administration (oral, parenteral, and others), end use (hospital, homecare, specialty center, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 6.4% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global inactivated hepatitis a vaccine market to 2030 by type (1.0ml and 0.5ml), application (hospital and clinic), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 9% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global hospice solution market to 2030 by type (continuous care, general hospital care, and others), application (home, medical institutions, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 4.1% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global clonazepam injection market to 2030 by type (2ml, 5ml, 10ml, and others), application (hospital, pharmacy, clinic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 16.0% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global cannabidiol market to 2030 by source (hemp and marijuana), sales type (business-to-business and business-to-consumers), end use (medical, personal use, pharmaceuticals, wellness, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)